Working… Menu
Trial record 1 of 9 for:    glufosfamide
Previous Study | Return to List | Next Study

Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT01954992
Recruitment Status : Recruiting
First Posted : October 7, 2013
Last Update Posted : August 6, 2019
Information provided by (Responsible Party):
Eleison Pharmaceuticals LLC.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 2021
Estimated Study Completion Date : June 2021